| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/20/2008 | EP1154804B1 Bioadhesive antibacterial wound healing composition |
| 02/20/2008 | EP1112497B1 Ykl-40 as a marker and prognostic indicator for cancers and detection of infections |
| 02/20/2008 | EP1109935B1 Two-colour differential display, used as a method for detecting regulated genes |
| 02/20/2008 | EP1071422B1 Association of Riluzole and levodopa for the treatment of Parkinson disease |
| 02/20/2008 | EP0986309B1 Uses of oil bodies |
| 02/20/2008 | EP0975347B1 Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists |
| 02/20/2008 | EP0768890B1 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 02/20/2008 | CN101128424A 吲哚化合物及其用途 Indole compounds and their use |
| 02/20/2008 | CN101128212A Drugs for nerve cell regeneration |
| 02/20/2008 | CN101125203A Sonosensitizer with oxygen-carrying function |
| 02/20/2008 | CN101125144A Compound medicine for treating diabetes |
| 02/20/2008 | CN101125143A Hypertension-treating compound medicine |
| 02/20/2008 | CN101125137A Pharmaceutical salts |
| 02/20/2008 | CN101125126A Method for preparing medical freeze-dried powder (injection) preparation |
| 02/20/2008 | CN100369632C Anti-cancer medicine composition |
| 02/20/2008 | CN100369631C Ultraviolet resistant formulation obtained from cell engineering technology |
| 02/20/2008 | CN100369630C Pharmaceutical compositions of cell lysate and processes for the production and use thereof |
| 02/19/2008 | US7332644 Screening for a developmental promoter or a developmental suppressor of oligodendrocytes, or a promoter or a suppressor of myelinogenesis, diagnostic for neuropsychiatric disorders |
| 02/19/2008 | US7332608 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents; synthesis |
| 02/19/2008 | US7332586 Active agent and a nuclear localization signal and methods of modulating gene expression and protein expression employing the nanoparticle delivery vehicle. A representative method includes providing a nanoparticle delivery vehicle comprising |
| 02/19/2008 | US7332579 Antiproliferative agents; anticancer agents |
| 02/19/2008 | US7332523 TNP-470 polymer conjugates and use thereof |
| 02/19/2008 | US7332505 Gastrointestinal disorders; facilitating healing and decreasing recurrence of ulcers; low dosage, reduced side effects |
| 02/19/2008 | US7332500 Heterocyclic antiviral compounds |
| 02/19/2008 | US7332496 Methods of using sodium channel blockers |
| 02/19/2008 | US7332493 [3-Methyl-4-(pyridin-3-yloxy)-phenyl]-(6-piperidin-3-ylethynyl-quinazolin-4-yl)-amine; selective inhibitors of receptor tyrosine kinases and non-receptor tyrosine kinases (eg: Ick, src, abl) or serine/threonine kinases (e.g.: cyclin dependent kinases); carcinoma |
| 02/19/2008 | US7332481 Thrombopoietin mimetics |
| 02/19/2008 | US7332287 Methods and compositions for diagnosing breast cancer |
| 02/19/2008 | US7332185 Component I selected from alpha acids and beta acids and component II selected from alpha acids, beta acids, essential oils, fats and waxes; specific inhibition of cyclooxygenase-2 with little effect on cyclooxygenase-1 |
| 02/19/2008 | US7332183 Multilayer dosage forms containing NSAIDs and triptans |
| 02/19/2008 | US7332177 Administering melatonin to ameliorate or prevent symptoms of hypertension developing in a patient who is resistant to the antihypertensive effect of an antihypertensive compound |
| 02/19/2008 | US7331951 Devices and methodologies useful in body aesthetics |
| 02/19/2008 | CA2431565C Pharmaceutical compositions based on anticholinergics and ciclesonide |
| 02/19/2008 | CA2380924C Compositions for treating viral infections, and methods therefor |
| 02/19/2008 | CA2338901C Prevention of migraine recurrence |
| 02/19/2008 | CA2304698C Endothelin antagonist and beta receptor blocking agent as combined preparations |
| 02/19/2008 | CA2273240C Compositions and methods for treating or preventing inflammatory diseases |
| 02/19/2008 | CA2226582C Non-allosteric gabaa agonists for treating sleep disorders |
| 02/19/2008 | CA2216856C Methods of screening for therapeutic agents using novel apoptosis-modulating proteins |
| 02/19/2008 | CA2173976C Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 02/19/2008 | CA2132613C Method and compositions for enhancing white blood cell functioning on a mucosal or cutaneous surface |
| 02/14/2008 | WO2008019198A1 Steroid-containing sustained release intraocular implants and related methods |
| 02/14/2008 | WO2008019106A1 Methods and compositions for the treatment of pulmonary hypertension using a combination of a calcium channel blocker and a phosphodiesterase inhibitor |
| 02/14/2008 | WO2008019065A1 Use of 3- (4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment of mantle cell lymphomas |
| 02/14/2008 | WO2008018600A1 THERAPEUTIC AGENT FOR ACCELERATION OF SPINAL NERVE REPAIR COMPRISING GHRELIN, DERIVATIVE THEREOF OR SUBSTANCE CAPABLE OF ACTING ON GHS-R1a AS ACTIVE INGREDIENT |
| 02/14/2008 | WO2008018597A1 Therapeutic agent for acceleration of spinal nerve repair comprising desacyl ghrelin or derivative thereof as active ingredient |
| 02/14/2008 | WO2008018555A1 HBsAg PARTICLE HAVING LOW ANTIGENICITY AND METHOD FOR PRODUCTION THEREOF |
| 02/14/2008 | WO2008018517A1 Therapeutic and/or preventive agent for disease accompanied by cell overgrowth, and polynucleotide useful as the active ingredient |
| 02/14/2008 | WO2008018448A1 Activator comprising biosurfactant as the active ingredient, mannosyl erythritol lipid and method of producing the same |
| 02/14/2008 | WO2008018447A1 Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
| 02/14/2008 | WO2008018275A1 Anti-obesity agent and use thereof |
| 02/14/2008 | WO2008017867A2 Antiretroviral solid oral composition with at least one water insoluble polymer |
| 02/14/2008 | WO2008017331A2 Peroral drug form comprising dienogest and ethinyl estradiol for contraception |
| 02/14/2008 | US20080039534 Methods for Identifying Modulators of RGS21 Activity, Compositions Comprising an RGS21 Modulator, and Methods of Use Thereof to Modulate Taste Sensation |
| 02/14/2008 | US20080039523 High volume and alternative methods of delivering homeopathic remedies |
| 02/14/2008 | US20080039522 Composition Containing a Complex Comprising a Metal Ion and a Carboxylate Ligand Having Anti-Inflammatory Activity |
| 02/14/2008 | US20080039463 Methods and Compositions |
| 02/14/2008 | US20080039419 Integrin-linked kinase and its uses |
| 02/14/2008 | US20080039411 Use Of Resistin Antisense Oligonucleotides And/Or Sirna Molecules In The Treatment Of Rheumatoid Arthritis |
| 02/14/2008 | US20080039364 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 02/14/2008 | US20080038552 Nanoscale And Supersaturated Solutions Of Mineral Substance And Trace Elements And A Process For The Production Of Nanoparticles, Mixtures Of Nanoparticles, Nanoscale Solutions, And Supersaturated Solutions In General |
| 02/14/2008 | US20080038403 Weight management system for obese animals |
| 02/14/2008 | US20080038370 Composition and method for treating the effects of diseases and maladies of the upper digestive tract |
| 02/14/2008 | US20080038330 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds of the lower respiratory tract |
| 02/14/2008 | US20080038314 Compositions and methods for the treatment and repair of defects or lesions in articular cartilage using synovial-derived tissue or cells |
| 02/14/2008 | US20080038312 Insertable or implantable medical devices suitable for gene therapy regimens |
| 02/14/2008 | US20080038297 Genetic adjuvants for viral vaccines |
| 02/14/2008 | US20080038236 Biocompatible scaffolds and adipose-derived stem cells |
| 02/14/2008 | US20080038233 Treatment of Spinal Conditions |
| 02/14/2008 | US20080038230 Method Of Cell Isolation |
| 02/14/2008 | US20080038228 Method |
| 02/14/2008 | US20080038205 Novel dermatophagoides proteins |
| 02/14/2008 | US20080038198 Method Of Screening Molecule Associated With Psychiatric Disorder |
| 02/14/2008 | DE102006037495A1 Use of substances with pharmacological action e.g. xenon for producing a preparation, in which components of the preparation are a gas or a lightly volatile fluid, for administration of the substances to humans or animals over the eyes |
| 02/14/2008 | DE102006037298A1 Pharmazeutische Zusammensetzung, insbesondere Antazidum A pharmaceutical composition, in particular antacid |
| 02/14/2008 | DE102006036801A1 Procedure for structured capturing and/or saving manufacturing data for reproducible production of cosmetic and/or pharmaceutical compositions in production layout, by non-extrapolating/extrapolating manufacturing data from another data |
| 02/14/2008 | CA2660689A1 Spinal nerve repair promoting therapeutics containing des-acyl ghrelin or its derivatives as an active ingredient |
| 02/14/2008 | CA2660517A1 Spinal nerve repair promoting therapeutics containing ghrelin or its derivatives or substances that act on ghs-rla as an active ingredient |
| 02/14/2008 | CA2659774A1 Use of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment of mantle cell lymphomas |
| 02/14/2008 | CA2659599A1 Amino alcohol derivative and immunosuppressive agent having same as an active ingredient |
| 02/14/2008 | CA2655509A1 Steroid-containing sustained release intraocular implants and related methods |
| 02/13/2008 | EP1887082A2 TADG-15: An extracellular serine protease overexpressed in carcinomas |
| 02/13/2008 | EP1887014A1 Human toll homologues |
| 02/13/2008 | EP1886994A1 Cyclic amine compounds as CCR5 antagonists |
| 02/13/2008 | EP1886695A1 Pharmaceutical combination of an aldosterone synthase inhibitor and a glucocorticoid receptor antagonist or a cortisol synthesis inhibitor or a corticotropin releasing factor antagonist |
| 02/13/2008 | EP1886694A1 Peroral formulation of dienogest and ethinylestradiol for contraception |
| 02/13/2008 | EP1886693A1 Agent for regeneration and/or protection of nerves |
| 02/13/2008 | EP1886692A1 Agent for improvement of insulin resistance |
| 02/13/2008 | EP1886677A1 Use of an inducing agent for the treatment of blood, viral and cellular disorders |
| 02/13/2008 | EP1886669A2 Phosphoglucan based immunotrophic preparation for the treatment of adenotonsillar hypertrophy |
| 02/13/2008 | EP1885872A1 Compositions and methods for treating hemostasis disorders associated with clec-2 signal transduction |
| 02/13/2008 | EP1885401A2 Anti-adhesin based passive immunoprophylactic |
| 02/13/2008 | EP1885389A1 Use of adnf polypeptides for treating peripheral neurotoxicity |
| 02/13/2008 | EP1885386A2 Non-natural chemokine receptor ligands and methods of use thereof |
| 02/13/2008 | EP1885355A1 Anticancer combination therapy using sunitinib malate |
| 02/13/2008 | EP1885353A1 Use of vitamin e tocotrienols for the inhibition of intracellularly obligate pathogen chlamydia |
| 02/13/2008 | EP1617827B1 Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances |
| 02/13/2008 | EP1517883B1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 02/13/2008 | EP1490025B1 Nanoparticulate compositions of map kinase inhibitors |
| 02/13/2008 | EP1463716B1 Pyrrolidine and piperidine derivates as nk1 antagonists |